1. Home
  2. CGBD vs AMPH Comparison

CGBD vs AMPH Comparison

Compare CGBD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGBD
  • AMPH
  • Stock Information
  • Founded
  • CGBD 2012
  • AMPH 1996
  • Country
  • CGBD United States
  • AMPH United States
  • Employees
  • CGBD N/A
  • AMPH N/A
  • Industry
  • CGBD Finance: Consumer Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGBD Finance
  • AMPH Health Care
  • Exchange
  • CGBD Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • CGBD 1.0B
  • AMPH 1.1B
  • IPO Year
  • CGBD 2017
  • AMPH 2014
  • Fundamental
  • Price
  • CGBD $14.05
  • AMPH $25.71
  • Analyst Decision
  • CGBD Hold
  • AMPH Hold
  • Analyst Count
  • CGBD 3
  • AMPH 5
  • Target Price
  • CGBD $14.00
  • AMPH $38.00
  • AVG Volume (30 Days)
  • CGBD 403.5K
  • AMPH 566.0K
  • Earning Date
  • CGBD 05-06-2025
  • AMPH 05-07-2025
  • Dividend Yield
  • CGBD 12.60%
  • AMPH N/A
  • EPS Growth
  • CGBD N/A
  • AMPH N/A
  • EPS
  • CGBD 1.30
  • AMPH 2.77
  • Revenue
  • CGBD $225,447,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • CGBD $12.82
  • AMPH $0.65
  • Revenue Next Year
  • CGBD $0.44
  • AMPH $5.26
  • P/E Ratio
  • CGBD $10.80
  • AMPH $9.30
  • Revenue Growth
  • CGBD N/A
  • AMPH 8.05
  • 52 Week Low
  • CGBD $13.12
  • AMPH $22.64
  • 52 Week High
  • CGBD $18.74
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • CGBD 45.38
  • AMPH 56.96
  • Support Level
  • CGBD $13.62
  • AMPH $23.74
  • Resistance Level
  • CGBD $14.19
  • AMPH $25.72
  • Average True Range (ATR)
  • CGBD 0.32
  • AMPH 0.73
  • MACD
  • CGBD 0.06
  • AMPH 0.24
  • Stochastic Oscillator
  • CGBD 49.71
  • AMPH 92.28

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: